Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment

Mov Disord. 2007 May 15;22(7):1043-6. doi: 10.1002/mds.21461.

Abstract

We describe a 51-year-old man with a 3-year history of multiple system atrophy, who developed a reversible posterior leukoencephalopathy syndrome (RPLS) after receiving prescription midodrine for therapeutic treatment of orthostatic hypotension. Typical reversible magnetic resonance imaging findings, following treatment with midodrine, suggested a possible relationship between midodrine treatment, supine hypertension, and RPLS, although a cause-and-effect relationship cannot be confirmed.

Publication types

  • Case Reports

MeSH terms

  • Adrenergic alpha-Agonists / therapeutic use*
  • Brain / drug effects
  • Brain / pathology
  • Dementia, Vascular / complications*
  • Dementia, Vascular / drug therapy
  • Dementia, Vascular / pathology
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Midodrine / therapeutic use*
  • Multiple System Atrophy / complications*
  • Multiple System Atrophy / drug therapy*

Substances

  • Adrenergic alpha-Agonists
  • Midodrine